|
|
|
|
NICE consults on preliminary decision not to recommend everolimus for advanced renal cell carcinoma
), the National Institute for Health and Clinical Excellence (NICE) has been unable to recommend everolimus (afinitor, Novartis) for the second line treatment of advanced renal cell carcinoma.This draft guidance is now available for public consultation.
|
|
|
GSK launches new rare diseases unit
GSK recently announced the formation of a new standalone unit specialising in the development and commercialisation of medicines for rare diseases.Over 5,500 rare diseases have been identified of which less than 10% are currently being treated, presenting a...
|
|
|
NICE welcomes topic suggestions for QOF
Let the jobs come to you!The National Institute for Health and Clinical Excellence (NICE) has today (Monday 8 February) opened the second and final phase of topic suggestion for the 2012/13 Quality and Outcomes Framework (QOF)! An online topic suggestion...
|
|
|
APCER Pharma Announces that LPC Pharma Group to Outsource Pharmacovigilance/Drug Safety to APCER
Let the jobs come to you!APCER Pharma announced that LPC Pharma Group is outsourcing its pharmacovigilance/drug safety operations to APCER! APCER is a leading global provider of comprehensive drug safety, regulatory services and risk management programs...
|
|
|
Solianis Monitoring AG on its Way to Success - Market Entry as Planned in 2011
Let the jobs come to you!ZURICH, February 8 /PRNewswire/ -- Solianis Monitoring AG presents its Non-Invasive, Continuous Glucose Monitoring System at the 3rd International Conference on Advanced Technologies and Treatments for Diabetes (Basel, Switzerland,...
|
|
|
Artimplant: Year-End Report 2009 is Published on February 11 2010 at Approximately 8:45 Am (CET) with Conferen
Let the jobs come to you!Regulatory News: Artimplant (STO:ARTIB) publishes Year-End Report 2009 on February 11 2010 at approximately 8:45 AM (CET)! The Interim Report is presented by CEO Hans Rosn and CFO Lars-Johan Cederbrant in conference call on...
|
|
|
AMAG Pharmaceuticals Provides Feraheme Safety Update
Let the jobs come to you!AMAG Pharmaceuticals, Inc! (NASDAQ: AMAG), a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and...
|
|
|
EpiCept Establishes At-the-Market Public Stock Offering Program
Let the jobs come to you!Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm: EPCT) announced today that it has established an at-the-market program through which it may sell, from time to time and at its sole discretion, shares of its...
|
|
|
Academic Pharmacy Committed to Setting the Standard of Patient-centered, Team-based Care
Let the jobs come to you!American Association of Colleges of Pharmacy (AACP): What: 2010 American Association of Colleges of Pharmacy (AACP) Interim Meeting When: February 7-10, 2010 Where: Crystal Gateway Marriott Hotel, 1700 Jefferson Davis Highway,...
|
|
|
Study Suggests Slide-On EndoSheath System Provides Several Advantages over Traditional Germicidal Immersio
Let the jobs come to you!Results of a clinical study presented Thursday, Feb! 4 at the annual Triological Society meetings in Orlando, Fla., suggest a sterile barrier sheath system has distinct advantages over germicidal immersion processes used to prevent...
|
